CME Group Inc (NASDAQ:CME) – Stock analysts at Jefferies Group dropped their FY2017 earnings per share (EPS) estimates for CME Group in a research note issued on Tuesday. Jefferies Group analyst D. Fannon now anticipates that the financial services provider will earn $4.74 per share for the year, down from their previous forecast of $4.80. Jefferies Group also issued estimates for CME Group’s Q4 2017 earnings at $1.10 EPS.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter last year, the business earned $1.05 earnings per share. CME Group’s revenue was up 5.8% on a year-over-year basis.

A number of other research analysts have also recently commented on CME. Keefe, Bruyette & Woods restated a “hold” rating and issued a $133.00 price target on shares of CME Group in a research report on Thursday, September 21st. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 27th. Wells Fargo & Co raised their price target on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. Barclays raised their price target on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 10th. Finally, Royal Bank of Canada raised their price target on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $144.22.

CME Group (CME) opened at $152.20 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a 12-month low of $114.82 and a 12-month high of $155.29. The company has a market capitalization of $51,790.00, a price-to-earnings ratio of 34.51, a P/E/G ratio of 2.04 and a beta of 0.72.

The firm also recently announced a dividend, which was paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th were given a $3.50 dividend. The ex-dividend date of this dividend was Wednesday, December 27th. This is a boost from CME Group’s previous dividend of $3.25. CME Group’s payout ratio is currently 59.86%.

In other CME Group news, CFO John W. Pietrowicz sold 7,500 shares of CME Group stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total value of $1,136,250.00. Following the transaction, the chief financial officer now owns 32,376 shares in the company, valued at $4,904,964. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jack J. Tobin sold 2,325 shares of CME Group stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $152.28, for a total value of $354,051.00. Following the completion of the transaction, the insider now owns 17,574 shares in the company, valued at approximately $2,676,168.72. The disclosure for this sale can be found here. In the last quarter, insiders sold 42,603 shares of company stock worth $6,250,726. Company insiders own 0.57% of the company’s stock.

Several large investors have recently added to or reduced their stakes in CME. PNC Financial Services Group Inc. grew its holdings in shares of CME Group by 11.9% during the second quarter. PNC Financial Services Group Inc. now owns 86,143 shares of the financial services provider’s stock worth $10,789,000 after purchasing an additional 9,142 shares during the last quarter. Thrivent Financial For Lutherans grew its holdings in shares of CME Group by 2.9% during the second quarter. Thrivent Financial For Lutherans now owns 12,860 shares of the financial services provider’s stock worth $1,611,000 after purchasing an additional 360 shares during the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of CME Group during the second quarter worth about $372,000. Quantitative Investment Management LLC bought a new stake in shares of CME Group during the second quarter worth about $38,411,000. Finally, UBS Asset Management Americas Inc. grew its holdings in shares of CME Group by 6.8% during the second quarter. UBS Asset Management Americas Inc. now owns 1,132,380 shares of the financial services provider’s stock worth $141,819,000 after purchasing an additional 72,531 shares during the last quarter. Institutional investors own 82.78% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/17/fy2017-eps-estimates-for-cme-group-inc-decreased-by-jefferies-group-cme.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.